Experimental Novartis radiopharma drug shows promise in early study
Corroborated by 4 sources from 4 publishers
TL;DR
Multiple sources report that a novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer.
Sources
1
Investing.com News
https://www.investing.com/news/stock-market-news/experimental-novartis-radiopharma-drug-shows-promise-in-early-study-4717844
2
CNBC 100727362
https://www.cnbc.com/2026/05/31/experimental-pill-promises-new-hope-for-deadly-pancreatic-cancer.html
3
ABC News Health Headlines
https://abcnews.com/Health/wireStory/experimental-pill-promises-new-hope-deadly-pancreatic-cancer-133462198
4
Fortune
https://fortune.com/2026/05/31/experimental-pill-daraxonrasib-survival-time-advanced-pancreatic-cancer